Flexion Therapeutics
-
Hospitals
Flexion Therapeutics Announces FDA Approval of Zilretta™ for Osteoarthritis (OA) Knee Pain
BURLINGTON, Mass., Oct. 06, 2017 (GLOBE NEWSWIRE) — Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that the U.S. Food and Drug…
Read More » -
Hospitals
Flexion Therapeutics Announces Issuance of Two New Patents
BURLINGTON, Mass., April 04, 2017 (GLOBE NEWSWIRE) — Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced the U.S. Patent and Trademark Office…
Read More » -
Financial
Company Shares of Flexion Therapeutics, Inc. (NASDAQ:FLXN) Drops by -23.72%
Flexion Therapeutics, Inc. (NASDAQ:FLXN) has lost 23.72% during the past week and dropped 46.87% in the last 4 weeks. The…
Read More » -
Financial
Company Shares of Flexion Therapeutics, Inc. Drops by -8.02%
Flexion Therapeutics, Inc. (NASDAQ:FLXN) has dropped 8.02% during the past week, however, the bigger picture is still very bullish; the…
Read More »